Home / Drug shortages / Methylphenidate Hydrochloride Tablet, Extended Release

Methylphenidate Hydrochloride Tablet, Extended Release — FDA Drug Shortage

Current — Lannett Company, Inc.

The FDA lists a drug shortage record for Methylphenidate Hydrochloride Tablet, Extended Release (tablet) from Lannett Company, Inc. with status Current. The shortage was first posted on 07/26/2023.

Shortage Details

Status
Current
Company
Lannett Company, Inc.
Package NDC
62175-311-37
Dosage Form
Tablet
Presentation
Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 62175-311-37)
Initial Posting
07/26/2023
Revised Date

FDA data resources